Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation

N Engl J Med. 2008 Jul 10;359(2):158-65. doi: 10.1056/NEJMoa0706300.

Abstract

Atrial fibrillation is a common arrhythmia that is hereditary in a small subgroup of patients. In a family with 11 clinically affected members, we mapped an atrial fibrillation locus to chromosome 1p36-p35 and identified a heterozygous frameshift mutation in the gene encoding atrial natriuretic peptide. Circulating chimeric atrial natriuretic peptide (ANP) was detected in high concentration in subjects with the mutation, and shortened atrial action potentials were seen in an isolated heart model, creating a possible substrate for atrial fibrillation. This report implicates perturbation of the atrial natriuretic peptide-cyclic guanosine monophosphate (cGMP) pathway in cardiac electrical instability.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Adult
  • Animals
  • Atrial Fibrillation / genetics*
  • Atrial Fibrillation / metabolism
  • Atrial Fibrillation / physiopathology
  • Atrial Natriuretic Factor / genetics*
  • Atrial Natriuretic Factor / metabolism
  • Chromosome Mapping
  • Chromosomes, Human, Pair 1
  • DNA Mutational Analysis
  • Female
  • Frameshift Mutation*
  • Guanosine Monophosphate / metabolism
  • Humans
  • Male
  • Middle Aged
  • Pedigree
  • Signal Transduction
  • White People / genetics

Substances

  • Guanosine Monophosphate
  • Atrial Natriuretic Factor